The study reveals that the inhibition of miR-29b could relieve inflammatory response and pulmonary fibrosis in LPS-conditioned ALI by modulating RTN4 and the Akt/ERK pathway. The gene discussed is AKT1; the disease is pulmonary fibrosis.